On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Alzheimer Scotland

InstitutionResearch output, impact & collaborations

Alzheimer Scotland is a institution indexed in ScholarIQ from OpenAlex.

What is known about Alzheimer Scotland?

ScholarIQrecord summary

Alzheimer Scotland is a research organisation in Edinburgh, GB. OpenAlex records 1,086 works and 145,856 citations for it. 87 researchers list it as their most recent affiliation.

How many works does Alzheimer Scotland have?

ScholarIQindexed works

Alzheimer Scotland has 1,086 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Alzheimer Scotland have?

ScholarIQcitation count

Alzheimer Scotland has 145,856 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Alzheimer Scotland?

ScholarIQresearcher count

Alzheimer Scotland has 87 researchers in the ScholarIQ index.

What is the average h-index at Alzheimer Scotland?

ScholarIQavg h-index

Alzheimer Scotland has an average h-index of 59 in OpenAlex.

What is the ROR of Alzheimer Scotland?

ScholarIQror

The ROR for Alzheimer Scotland is on the source record.

What is the OpenAlex record for Alzheimer Scotland?

ScholarIQopenalex

The OpenAlex for Alzheimer Scotland is on the source record.

Who are the most-cited researchers behind Alzheimer Scotland?

ScholarIQtop researchers by citations
1
Michael E. Ward · Reproductive tract infections research
414 works18,695 citations
2
Tom C. Russ · Dementia and Cognitive Impairment Research
262 works12,253 citations

What are the most-cited papers on Alzheimer Scotland?

ScholarIQmost cited works
Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia
Saion Chatterjee, Sanne A. E. Peters, Mark Woodward, Silvia Mejía-Arango, G. David Batty, Nigel Beckett, Alexa Beiser, Amy R. Borenstein, Paul K. Crane, Mary N. Haan, Linda B. Hassing, Kathleen M. Hayden, Yutaka Kiyohara, Eric B. Larson, Chung‐Yi Li, Toshiharu Ninomiya, Tomoyuki Ohara, Ruth Peters, Tom C. Russ, Sudha Seshadri, Bjørn Heine Strand, Rod Walker, Weili Xu, Rachel Huxley
Diabetes Care. 2015719 CitationsOPEN ACCESS
Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies
Tom C. Russ, Emmanuel A. Stamatakis, Mark Hamer, John M. Starr, Mika Kivimäki, G. David Batty
BMJ. 2012647 CitationsOPEN ACCESS
Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model
Shoutang Wang, Meer Mustafa, Carla M. Yuede, Santiago V. Salazar, Philip Kong, Hua Long, Michael E. Ward, Omer Siddiqui, Robert Paul, Susan Gilfillan, Adiljan Ibrahim, Hervé Rhinn, Ilaria Tassi, Arnon Rosenthal, Tina Schwabe, Marco Colonna
The Journal of Experimental Medicine. 2020574 CitationsOPEN ACCESS
Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data
on behalf of Dementias Platform UK and UK Biobank, Tim Wilkinson, Christian Schnier, Kathryn Bush, Kristiina Rannikmäe, David Henshall, Chris Lerpiniere, Naomi E. Allen, Robin Flaig, Tom C. Russ, Deborah Bathgate, Suvankar Pal, John T. O’Brien, Cathie Sudlow
European Journal of Epidemiology. 2019476 CitationsOPEN ACCESS
Environmental risk factors for dementia: a systematic review
Lewis Killin, John M. Starr, Ivy Shiue, Tom C. Russ
BMC Geriatrics. 2016437 CitationsOPEN ACCESS

How much of the research on Alzheimer Scotland is open access?

ScholarIQopen access share
89%OPEN ACCESS
Gold
11%
Green
11%
Hybrid
44%
Bronze
22%
Closed
11%

Related on ScholarIQ

470M+ articles · 14-day free trial